About Auarice Pharmaceuticals Private Limited
Data last updated:
Auarice Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 April 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2013PTC242662. Its GSTIN is 27AALCA5687M1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sandeep Manoharlal Agrawal and Manoharlal Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at U 49 Ujwal Society Narendra Nagar, Nagpur, Maharashtra, India – 440015.
As per the financials filed for FY 2025, the company reported a revenue of ₹58.96 Lakh, a decline of 4% compared to the previous year. For the same year it recorded a net profit of ₹53,104 (net margin 0.9%) and EBITDA of ₹58,794 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 4% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website auarice.in.
Company details
Contact details
Auarice Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its website is auarice.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressU 49 Ujwal Society Narendra Nagar, Nagpur, Maharashtra, India – 440015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Auarice Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Auarice Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Auarice Pharmaceuticals Private Limited, buy the company report.
Financials of Auarice Pharmaceuticals Private Limited
FY 2025 filings availableAuarice Pharmaceuticals Private Limited reported revenue of ₹58.96 Lakh (down 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 4% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹58,794 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53,104 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Auarice Pharmaceuticals Private Limited, buy the company report.
Board of directors of Auarice Pharmaceuticals Private Limited
Auarice Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Manoharlal Agrawal | Director | 26 Aug 2022 | 4 Years 2 Months | Current |
| Manoharlal Agrawal | Director | 02 Sep 2022 | 4 Years 2 Months | Current |
| Nilesh Deodhar | Director | 30 Apr 2013 | 13 Years 6 Months | Current |
Auditor
Auarice Pharmaceuticals Private Limited is audited by DINESH CHANDAK & CO. for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DINESH CHANDAK & CO. | FY 2018 | 147615W |
Shareholding
The shareholding of Auarice Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Auarice Pharmaceuticals Private Limited, buy the company report.
Legal cases
Auarice Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Edelweiss Housing Finance Limited. | Disposed |
To see the full case history of Auarice Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Auarice Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Auarice Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCA5687M1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Auarice Pharmaceuticals Private Limited, buy the company report.
Recent activity
Auarice Pharmaceuticals Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Manoharlal Agrawal was appointed as Director on 02 Sep 2022.
Frequently asked questions
Auarice Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 April 2013 (13+ years old) and is registered under CIN U74999MH2013PTC242662.
Auarice Pharmaceuticals has 3 current directors:
- Sandeep Manoharlal Agrawal - Director
- Manoharlal Agrawal - Director
- Nilesh Deodhar - Director
The latest financial statements of Auarice Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Auarice Pharmaceuticals is 27AALCA5687M1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Auarice Pharmaceuticals is U74999MH2013PTC242662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Auarice Pharmaceuticals has 1 court case on record: 1 filed against it.
Auarice Pharmaceuticals was incorporated on 30 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.
Manoharlal Agrawal was appointed as Director on 02 Sep 2022. Sanjay Anandrao Lambat ceased to be Director on 30 Aug 2022. Gauri Nilesh Deodhar ceased to be Director on 26 Aug 2022. Auarice Pharmaceuticals has 6 board changes on record in total.
Auarice Pharmaceuticals can be reached through the website auarice.in. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Auarice Pharmaceuticals is at U 49 Ujwal Society Narendra Nagar, Nagpur, Maharashtra, India – 440015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
